Af­ter a years-long de­lay, FDA ap­proves first gener­ic ver­sions of EpiPen

The FDA on Thurs­day ap­proved Te­va Phar­ma­ceu­ti­cals’ first gener­ic ver­sion of EpiPen and EpiPen Jr (ep­i­neph­rine) au­to-in­jec­tor for the emer­gency treat­ment of al­ler­gic re­ac­tions, in­clud­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.